Is CME a good stock to buy? We came across a bullish thesis on CME Group Inc. on DividendInvestor’s Substack. In this article, we will summarize the bulls’ thesis on CME. CME Group Inc.’s share was trading at $286.82 as of May 5th. CME’s trailing and forward P/E were 24.77 and 23.75 respectively according to Yahoo Finance.
Copyright: convisum / 123RF Stock Photo
CME Group operates as the core infrastructure layer of global finance, effectively monetizing volatility by acting as the central marketplace for risk transfer across interest rates, commodities, and financial derivatives. While the market focuses on its modest 1.79% regular dividend yield and a share price roughly 12% below its peak, this overlooks a differentiated capital return model combining a steadily growing quarterly dividend with a substantial variable dividend tied to annual free cash flow.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
In 2025, this variable payout reached $6.15 per share, bringing the total yield to approximately 4.2%, far above what surface-level metrics suggest. The company’s dominance is underpinned by deep liquidity network effects and unmatched scale, with Q1 2026 average daily volume hitting a record 36.2 million contracts, up 22% year-over-year, including 30% growth internationally, reflecting a structural increase in global hedging demand.
Financially, CME demonstrates exceptional profitability, with 64.9% operating margins and strong free cash flow conversion, supported by pricing power, recurring market data revenue, and minimal capital intensity. Its balance sheet remains highly conservative with near-zero leverage, ensuring dividend sustainability.
While risks include volume cyclicality, regulatory shifts, technological disruption, and variability in the annual dividend, the long-term thesis remains intact as CME continues to benefit from persistent macro uncertainty. With consistent revenue growth, expanding margins, and a disciplined capital return framework, the company represents a high-quality compounder where total shareholder returns are driven by both income and structural growth in trading activity.
Previously, we covered a bullish thesis on CME Group Inc. (CME) by Magnus Ofstad in January 2025, which highlighted the company’s leadership in derivatives trading, transaction-driven revenue model, and resilience supported by strong interest rate futures volumes and dividend strength. CME’s stock price has appreciated by approximately 21.04% since our coverage. DividendInvestor shares a similar view but emphasizes on CME’s dual-dividend structure and margin strength.
CME Group Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 74 hedge fund portfolios held CME at the end of the fourth quarter which was 77 in the previous quarter. While we acknowledge the risk and potential of CME as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CME and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
